Obesity and chronic metabolic disease is killing COVID -19 patients: now is the time to eat real food, protect the NHS and save lives. A healthcare system issue Last week I inquired as to how a close friend of mine, a director of research and a senior clinical doctor in one of New York’s’ busiest […]
Some payers are imposing further restrictions or eliminating coverage of GLP-1 drugs while either maintaining access to bariatric surgery or making it easier to obtain.
This pooled analysis including 4 trials examines the long-term glycemic control and safety of bariatric surgery compared with medical/lifestyle management of type 2 diabetes.
Annual price of semaglutide would have to drop significantly to be comparable
This economic evaluaton study assesses the cost-effectiveness of semaglutide compared with endoscopic sleeve gastroplasty over 5 years for individuals with class II obesity.
Annual price of semaglutide would have to drop significantly to be comparable
Metabolic dysfunction-associated steatohepatitis (MASH) is a leading etiology of chronic liver disease worldwide. In this review, Tincopa et al. highlight challenges and potential solutions in drug…
Nature Metabolism – Klingelhuber, Frendo-Cumbo et al. develop a proteomic atlas elucidating the intracellular spatiotemporal changes in protein levels and localizations during human adipogenesis.
This pooled analysis including 4 trials examines the long-term glycemic control and safety of bariatric surgery compared with medical/lifestyle management of type 2 diabetes.
Different bacterial species affect the onset and development of obesity in men vs women.
A register-based study identified three distinct BMI trajectory groups among patients with newly diagnosed type 2 diabetes. In a four-year follow-up, most patients followed a…
